0.95
price down icon2.68%   -0.0262
 
loading

Rallybio Corp Stock (RLYB) Forecast

The Rallybio Corp (RLYB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.0693, representing a +12.56% increase from the current price of $0.95. The highest analyst price target is $1.595, and the lowest is $0.5437.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RLYB Price Target
Average 4.4395 (+367.32% Upside)
loading

Is Rallybio Corp (RLYB) A Buy Now?

Oscillators
Name Value Action
RSI(14) 37.53 Neutral
STOCH(9,6) 13.26 Buy
STOCHRSI(14) 28.69 Neutral
MACD(12,26) -0.0159 Sell
ADX(14) 24.73 Neutral
William %R -93.55 Buy
CCI(14) -120.07 Sell
Buy: 2 Sell: 2 Neutral: 3
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
1.0712
Sell
1.0319
Sell
MA20
1.0766
Sell
1.0519
Sell
MA50
1.0529
Sell
1.0694
Sell
MA100
1.0923
Sell
1.1531
Sell
MA200
1.3514
Sell
1.5254
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, RLYB could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on RLYB, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 37.53 indicates that RLYB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 13.26 indicates that RLYB is oversold. This indicates that RLYB price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 28.69 indicates that RLYB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 24.73 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -120.07 indicates that RLYB is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term RLYB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Rallybio Corp financial reports and earnings history, Rallybio Corp (RLYB) stock could reach $3.7904 by 2030, $50.66 by 2040 and $71.03 by 2050. See the projected annual prices until 2050 of the Rallybio Corp stock below:

  • Rallybio Corp (RLYB) is expected to reach an average price of $17.54 in 2035, with a high prediction of $18.03 and a low estimate of $15.30. This indicates an $1,746% rise from the last recorded price of $0.95.
  • Rallybio Corp (RLYB) stock is projected to chart a bullish course in 2040, with an average price target of $50.26, representing an $5,191% surge from its current level. The forecast ranges from a conservative $50.95 to a sky-high $50.66.
  • Our analysts predict Rallybio Corp (RLYB) to jump 3,030% by 2045, soaring from $29.93 to an average price of $29.74, potentially reaching $31.35. While $29.93 is the low estimate, the potential upside is significant.
  • Rallybio Corp (RLYB) stock is expected to climb by 2050, reaching an average of $70.18, a $7,287% jump from its current level. However, a wide range of estimates exists, with high and low targets of $71.03 and $70.96, respectively, highlighting the market's uncertainty.

Rallybio Corp Stock (RLYB) Year by Year Forecast

Rallybio Corp Stock (RLYB) Price Forecast for 2025

Rallybio Corp Stock (RLYB) is expected to reach an average price of $4.4395 in 2025, with a high prediction of $8.8148 and a low estimate of $0.0642. This indicates an +367.32% rise from the last recorded price of $0.95.
Month Average Low High Change from today's price
January, 2025 $0.9712 $0.5437 $1.595 +2.23%
February, 2025 $1.534 $0.1377 $3.1676 +61.47%
March, 2025 $4.7991 $0.3903 $7.0791 +405.17%
April, 2025 $0.0805 $1.0095 $6.3817 -91.52%
May, 2025 $1.4757 $0.1757 $1.7557 +55.33%
June, 2025 $4.3108 $1.2421 $4.4108 +353.77%
July, 2025 $5.2322 $2.7234 $5.5571 +450.76%
August, 2025 $4.0474 $3.1271 $8.8148 +326.04%
September, 2025 $2.8225 $0.55 $4.33 +197.11%
October, 2025 $0.696 $1.116 $3.4451 -26.73%
November, 2025 $0.4809 $0.9309 $1.3728 -49.38%
December, 2025 $1.0905 $0.0642 $2.3005 +14.79%

Rallybio Corp Stock (RLYB) Price Forecast for 2026

The predicted value for Rallybio Corp (RLYB) in 2026 is set at an average of $2.2268. Estimates vary from a peak of $4.4288 to a trough of $0.0248, indicating an +134.40% surge from the present price of $0.95.
Month Average Low High Change from today's price
January, 2026 $1.3257 $0.4432 $1.5168 +39.54%
February, 2026 $0.2292 $0.3992 $4.3758 -75.87%
March, 2026 $0.3641 $0.5741 $0.7838 -61.68%
April, 2026 $0.2174 $0.0248 $1.0674 -77.12%
May, 2026 $3.2325 $0.2337 $3.3425 +240.26%
June, 2026 $1.1176 $0.9226 $4.4288 +17.65%
July, 2026 $1.7191 $0.5702 $2.0065 +80.96%
August, 2026 $1.4342 $0.8866 $2.2379 +50.97%
September, 2026 $1.1056 $0.8906 $2.1494 +16.38%
October, 2026 $0.1492 $0.1992 $1.3019 -84.29%
November, 2026 $0.4341 $0.1229 $1.1834 -54.31%
December, 2026 $0.1327 $1.0327 $0.7889 -86.04%

Rallybio Corp Stock (RLYB) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Rallybio Corp (RLYB) is $4.3369, with a high forecast of $8.6257 and a low forecast of $0.0481. This indicates an +356.52% increase from the last price of $0.95.
Month Average Low High Change from today's price
January, 2027 $0.6775 $0.3164 $0.3736 -28.68%
February, 2027 $1.2224 $0.8912 $1.1356 +28.67%
March, 2027 $0.0341 $0.5608 $1.1161 -96.42%
April, 2027 $0.4658 $0.0553 $0.4016 -50.97%
May, 2027 $0.0807 $0.1907 $1.5631 -91.51%
June, 2027 $8.4674 $0.0481 $7.7574 +791.31%
July, 2027 $8.2271 $8.467 $7.9535 +766.02%
August, 2027 $2.9569 $3.2769 $6.6146 +211.25%
September, 2027 $5.004 $2.9666 $3.0617 +426.74%
October, 2027 $7.6737 $7.0714 $6.0163 +707.76%
November, 2027 $9.5635 $8.7312 $7.6635 +906.68%
December, 2027 $6.3806 $6.5706 $8.6257 +571.64%

Rallybio Corp Stock (RLYB) Price Forecast for 2028

In 2028, Rallybio Corp (RLYB) is projected to reach an average price of $5.6663, with a high projection of $10.07 and a low estimate of $1.2578. This indicates an +496.46% rise from the last price of $0.95.
Month Average Low High Change from today's price
January, 2028 $6.5103 $5.2655 $4.5903 +585.30%
February, 2028 $9.36 $7.1678 $7.3826 +885.27%
March, 2028 $8.0472 $9.3172 $10.07 +747.07%
April, 2028 $5.6569 $7.3569 $5.762 +495.46%
May, 2028 $8.9341 $3.7342 $6.7141 +840.43%
June, 2028 $8.0738 $8.4038 $8.5015 +749.87%
July, 2028 $5.8335 $6.3035 $6.4512 +514.05%
August, 2028 $3.5506 $3.0658 $3.6409 +273.75%
September, 2028 $0.5504 $2.0804 $2.8481 -42.07%
October, 2028 $5.8201 $1.2578 $4.3301 +512.64%
November, 2028 $7.5172 $4.1949 $6.886 +691.29%
December, 2028 $7.7569 $7.3895 $6.8969 +716.52%

Rallybio Corp Stock (RLYB) Price Forecast for 2029

The 2029 price forecast for Rallybio Corp Stock (RLYB) is $3.9696 on average, with a high prediction of $6.1768 and a low estimate of $1.7624. This represents an +317.85% increase from the previous price of $0.95.
Month Average Low High Change from today's price
January, 2029 $5.9541 $6.6741 $6.1768 +526.75%
February, 2029 $5.2238 $5.089 $4.9515 +449.88%
March, 2029 $3.3535 $3.6385 $4.2638 +253.00%
April, 2029 $6.2233 $3.521 $5.6933 +555.08%
May, 2029 $4.8204 $5.6704 $5.543 +407.41%
June, 2029 $3.4101 $3.8901 $4.3078 +258.96%
July, 2029 $1.7498 $1.7624 $2.3358 +84.19%
August, 2029 $2.587 $2.1473 $2.9221 +172.31%
September, 2029 $2.4967 $2.5819 $2.4419 +162.81%
October, 2029 $2.4139 $2.639 $2.3116 +154.09%
November, 2029 $3.6836 $2.8213 $3.2436 +287.74%
December, 2029 $2.6333 $3.1483 $3.201 +177.19%

Rallybio Corp Stock (RLYB) Price Forecast for 2030

Rallybio Corp Stock (RLYB) is expected to reach an average price of $10.05 in 2030, with a high forecast of $18.63 and a low forecast of $1.4636. This signifies an +957.61% surge from the last price of $0.95.
Month Average Low High Change from today's price
January, 2030 $4.3604 $2.9207 $3.7904 +358.99%
February, 2030 $3.1802 $3.2702 $3.8679 +234.75%
March, 2030 $3.9299 $3.3876 $3.4499 +313.67%
April, 2030 $3.1496 $3.6946 $3.7079 +231.54%
May, 2030 $2.4868 $2.1793 $2.737 +161.76%
June, 2030 $2.2765 $2.3465 $2.4316 +139.63%
July, 2030 $1.5762 $1.4636 $1.6888 +65.91%
August, 2030 $17.76 $19.09 $18.63 +1,770%
September, 2030 $13.66 $18.19 $17.66 +1,338%
October, 2030 $12.57 $13.56 $13.23 +1,224%
November, 2030 $16.52 $13.02 $15.02 +1,639%
December, 2030 $18.70 $17.45 $17.14 +1,869%
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Cap:     |  Volume (24h):